China Shineway Pharmaceutical Group Limited
CSWYY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $255 | $253 | $158 | $265 |
| - Cash | $6,140 | $5,889 | $5,026 | $4,206 |
| + Debt | $347 | $301 | $7 | $15 |
| Enterprise Value | -$5,538 | -$5,335 | -$4,861 | -$3,925 |
| Revenue | $3,778 | $4,517 | $3,951 | $3,224 |
| % Growth | -16.4% | 14.3% | 22.6% | – |
| Gross Profit | $2,832 | $3,394 | $2,938 | $2,410 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| EBITDA | $1,221 | $1,420 | $1,104 | $904 |
| % Margin | 32.3% | 31.4% | 27.9% | 28% |
| Net Income | $840 | $970 | $723 | $557 |
| % Margin | 22.2% | 21.5% | 18.3% | 17.3% |
| EPS Diluted | 444 | 513.4 | 384 | 296 |
| % Growth | -13.5% | 33.7% | 29.7% | – |
| Operating Cash Flow | $963 | $933 | $1,110 | $703 |
| Capital Expenditures | -$140 | -$144 | -$129 | -$94 |
| Free Cash Flow | $823 | $788 | $980 | $610 |